يعرض 1 - 20 نتائج من 20 نتيجة بحث عن '"9vhpv"', وقت الاستعلام: 0.84s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal

    المساهمون: De Vincenzo, Rosa Pasqualina, Caporale, Nicola, Bertoldo, V., Ricci, Caterina, Evangelista, M. T., Bizzarri, Nicolo', Anchora, L. P., Scambia, Giovanni, Capelli, Giovanni

    Relation: info:eu-repo/semantics/altIdentifier/pmid/34204645; info:eu-repo/semantics/altIdentifier/wos/WOS:000666479100001; volume:9; issue:6; firstpage:643; lastpage:655; numberofpages:13; issueyear:N/A; journal:VACCINES; http://hdl.handle.net/10807/211461; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85108667371

  6. 6
    Academic Journal
  7. 7
    Academic Journal
  8. 8
    Academic Journal

    المساهمون: Tognon, M., Tagliapietra, A., Magagnoli, Federica, Mazziotta, C., Oton-Gonzalez, Lucia., Lanzillotti, C., Vesce, F., Contini, C., Rotondo, J. C., Martini, F.

    وصف الملف: ELETTRONICO

    Relation: info:eu-repo/semantics/altIdentifier/pmid/32854278; info:eu-repo/semantics/altIdentifier/wos/WOS:000581957900001; volume:8; issue:3; firstpage:473-1; lastpage:473-14; numberofpages:14; journal:VACCINES; http://hdl.handle.net/11392/2422032; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85090607719; https://www.mdpi.com/2076-393X/8/3/473/pdf?version=1598348621; https://www.mdpi.com/2076-393X/8/3/473

  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11

    المصدر: Vaccine

  12. 12

    المصدر: Papillomavirus Research
    International Agency for Research on Cancer, GLOBOCAN 2012: estimated cancer incidence (2012) Mortal. Preval. Worldw., http://globocan.iarc.fr/Pages/fact_sheets_population.aspx, (accessed 12 June 2017)
    Repositorio EdocUR-U. Rosario
    Universidad del Rosario
    instacron:Universidad del Rosario
    Papillomavirus Research, Vol 5, Iss, Pp 63-74 (2018)

    مصطلحات موضوعية: Male, Vagina Smear, Antibody Response, GMT, geometric mean titer, Antibodies, Viral, Papiloma, Injection Site Pruritus, 0302 clinical medicine, PCR, polymerase chain reaction, Mexico city, Human Papillomavirus Type 58, Medicine, Dna viral, Child, Human Papillomavirus Type 52, Vulva Disease, Injection Site Erythema, Vaccine Immunogenicity, Vaccination, Headache, HPV-9 cLIA, 9-valent competitive Luminex immunoassay, Hispanic or Latino, Randomized Controlled Trial, Priority Journal, Persistent Infection, AE, adverse event, Human, medicine.medical_specialty, Vomiting, HPV, human papillomavirus, Persistent infection, Article, WHO, World Health Organization, lcsh:Infectious and parasitic diseases, 03 medical and health sciences, Drug Fatality, Vacuna contra papilomavirus, Human Papillomavirus Type 33, Neoplasias del cuello uterino, Humans, Human Papillomavirus Type 31, Papillomavirus Vaccines, Gynecological oncology, Public health, Human Papillomavirus, Curitiba, United States, Double Blind Procedure, Latin America, DNA, Viral, Cervical cancer, Human Papillomavirus Type 45, Latin Americans, Injection Site Pain, Hispanic, Uterine Cervical Neoplasms, Human papillomavirus vaccine, Cervical Cancer, 9vHPV, 9-valent human papillomavirus, Immunogenicity, Vaccine, Wart Virus Vaccine, 030212 general & internal medicine, CIN, cervical intraepithelial neoplasia, Papillomaviridae, Vagina Disease, 9vHPV, PPI, per-protocol immunogenicity, biology, Nausea, PPE, per-protocol efficacy, Treatment Outcome, Infectious Diseases, Blood Analysis, Seroconversion, Injection Site Swelling, Christian ministry, Female, Adult, Uterine Cervix Dysplasia, Human papillomavirus, Fever, Adolescent, Disease Association, mMU, milli-Merck units, Major Clinical Study, Dizziness, Virus Antibody, Young Adult, 9Vhpv, Drug Safety, Double-Blind Method, 030225 pediatrics, Virology, Virus Dna, Uterine Cervix Cytology, lcsh:RC109-216, Controlled Study, Papillomavirus Infection, Adverse Event, business.industry, Cl, confidence interval, Papillomavirus Infections, qHPV, quadrivalent human papillomavirus, biology.organism_classification, Antibody Blood Level, Drug Efficacy, Gynecological Examination, business, SD, standard deviation, Humanities, Vaccine

    وصف الملف: application/pdf

  13. 13
  14. 14

    المصدر: Papillomavirus Research, Vol 10, Iss, Pp 100203-(2020)
    Papillomavirus Research

    مصطلحات موضوعية: Male, Time Factors, BMI, body mass index, GMT, geometric mean titer, Effectiveness, Antibodies, Viral, Genital warts, IgG-LIA, immunoglobulin G Luminex Immunoassay, 0302 clinical medicine, Immunogenicity, Vaccine, PCR, polymerase chain reaction, Nine-valent human papillomavirus vaccine, LVPP, labial/vulvar/perineal/perianal, 030212 general & internal medicine, cLIA, competitive Luminex Immunoassay, Child, Papillomaviridae, CIN, cervical intraepithelial neoplasia, PIN, penile intraepithelial neoplasia, Colposcopy, education.field_of_study, Intraepithelial neoplasia, PPI, per-protocol immunogenicity, medicine.diagnostic_test, Immunogenicity, Vaccination, VaIN, vaginal intraepithelial neoplasia, Infectious Diseases, 030220 oncology & carcinogenesis, AIS, adenocarcinoma in situ, Female, medicine.medical_specialty, Adolescent, VIN, vulvar intraepithelial neoplasia, Population, HPV, human papillomavirus, EEC, endo-/ectocervical, Article, WHO, World Health Organization, lcsh:Infectious and parasitic diseases, 03 medical and health sciences, PPE, per-protocol effectiveness, Virology, Internal medicine, medicine, 9vHPV, nine-valent human papillomavirus, Humans, Sex organ, lcsh:RC109-216, Papillomavirus Vaccines, LTFU, long-term follow-up, bHPV, bivalent human papillomavirus, education, Long-term follow-up, SAE, serious adverse event, business.industry, Papillomavirus Infections, qHPV, quadrivalent human papillomavirus, medicine.disease, Interim analysis, CI, confidence interval, Human medicine, business, SD, standard deviation, HN-TS, HPV-naïve, type-specific, Follow-Up Studies

  15. 15

    المصدر: Papillomavirus Research, Vol 10, Iss, Pp 100205-(2020)
    Papillomavirus Research

  16. 16

    المصدر: The Journal of Infectious Diseases

  17. 17
  18. 18

    المصدر: Human vaccines & immunotherapeutics
    Human Vaccines & Immunotherapeutics

    وصف الملف: pdf; Print-Electronic

  19. 19

    المصدر: Petersen, L K, Restrepo, J, Moreira, E D, Iversen, O-E, Pitisuttithum, P, Van Damme, P, Joura, E A, Olsson, S-E, Ferris, D, Block, S, Giuliano, A R, Bosch, X, Pils, S, Cuzick, J, Garland, S M, Huh, W, Kjaer, S K, Bautista, O M, Hyatt, D, Maansson, R, Moeller, E, Qi, H, Roberts, C & Luxembourg, A 2017, ' Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine-A combined analysis of five phase III clinical trials ', Papillomavirus Research, vol. 3, pp. 105-115 . https://doi.org/10.1016/j.pvr.2017.03.002
    Petersen, L K, Restrepo, J, Moreira, E D, Iversen, O-E, Pitisuttithum, P, Van Damme, P, Joura, E A, Olsson, S-E, Ferris, D, Block, S, Giuliano, A R, Bosch, X, Pils, S, Cuzick, J, Garland, S M, Huh, W, Kjaer, S K, Bautista, O M, Hyatt, D, Maansson, R, Moeller, E, Qi, H, Roberts, C & Luxembourg, A 2017, ' Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine-A combined analysis of five phase III clinical trials ', Papillomavirus research (Amsterdam, Netherlands), vol. 3, pp. 105-115 . https://doi.org/10.1016/j.pvr.2017.03.002
    Papillomavirus Research, Vol 3, Iss, Pp 105-115 (2017)
    Papillomavirus Research

    وصف الملف: application/pdf; pdf

  20. 20
    Electronic Resource